The Roles of Nurses in Taking Care of Pregnant Women Being Active Hepatitis B Virus Carriers

Main Article Content

กาญจนา ศรีสวัสดิ์
ปธานิน แสงอรุณ

Abstract

Hepatitis B virus is a partially double-stranded DNA virus. Once it enters the body, it focuses on destroying liver cells. The hepatitis B virus contains an outer envelope and an inner core. The outer envelope is composed of a surface protein called the hepatitis B surface antigen or HBsAg (hepatitis B core antigen). The inner core of the virus is a protein shell referred to as the hepatitis B core, which contains the hepatitis B virus DNA and enzymes used in viral replication. Hitpatitis B is spread by percutaneous or mucosa exposure to infected blood and various body fluides, as well as through saliva. When pregnant women have hepatitis B virus, they are at risk to pass the virus to their fetuses as the transmission can happen during pregnancy, delivery, and postpartum period. Therefore, nurses who play an important role in caring of pregnant women should have knowledge and understanding about caring of pregnant women with hepatitits B carrier continually from delivery and after giving birth periods to prevent the spread of the virus in providing recommendation for taking care of themselves to promote their health, reduce severity of the disease, and reduce complications that probably happen to fetuses.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
ศรีสวัสดิ์ก, แสงอรุณป. The Roles of Nurses in Taking Care of Pregnant Women Being Active Hepatitis B Virus Carriers. J Royal Thai Army Nurses [Internet]. 2019Dec.28 [cited 2020Feb.20];20(3):1-. Available from: https://he01.tci-thaijo.org/index.php/JRTAN/article/view/232888
Section
Academic articles

References

1. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendation Reproductive. 2015; 64 (RR-03) :1-137.

2. Tang LSY, Covert E, Wilson E, Kottilil S. Chronic Hepatitis B Infection: A Review. JAMA. 2018; 319: 1802-13.

3. Leroi C, Adam P, Khamduang W, Kawilapat S, Ngo-Giang-Huong N, Ongwandee S, et al. Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. Internal Journal Infection Dissemination. 2016; 51:36-43.

4. Liu CP, Zeng YL, Zhou M, Chen LL, Hu R, Wang L, et al. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis. Internal Medical. 2015; 54: 711-6.

5. Yin Y, Wu L, Zhang J, Zhou J, Zhang P, Hou H. Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus. Jounal Infection. 2013; 66: 447-52.

6. Zhang L, Gui X, Wang B, Ji H, Yisilafu R, Li F, et al. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission. European Journal of Pediatric. 2014; 173: 1161-8.

7. Dionne-Odom J, Tita AT, Silverman NS. Hepatitis B in pregnancy screening, treatment, prevention of vertical transmission. America Journal Obstetrice Gynecology. 2016; 214:6-14.

8. Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Internal Journal Infection Dissemination. 2012;16: e82-8.

9. Zou H, Chen Y, Duan Z, Zhang H, Pan C. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBs Ag-positive mothers. Journal Viral Hepatitis. 2012; 19: e18-25.

10. Chamroonkul N, Piratvisuth T. Hepatitis B During Pregnancy in Endemic Areas: Screening, Treatment, and Prevention of Mother-to-child Transmission. Pediatric Drugs.2017; 19:173-81.

11. Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology Internal. 2016;10: 1-98.

12. Liver Disease Association of Thailand. Thailand practice guideline for management of chronic hepatitis B and C. Nonthaburi: Photo Print Partnership. 2015; 1-33. (in Thai)

13. Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, et al. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load. Neonatal England Journal Medical. 2016; 374:2324-34.

14. Brown RS, Jr, McMahon BJ, Lok AS, Wong JB, Ahmed AT, Mouchli MA, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology. 2016; 63: 319-33.

15. Sarri G, Westby M, Bermingham S, Hill-Cawthorne G, Thomas H. Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance. Biological Medical Journal. 2013; 346: f3893.

16. Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, et al. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B Neonatal. England Journal Medical. 2018; 378: 911-23.

17. Chaichana J, Prachusilpa G. A Study of Professional Nurse Roles in Sub-District Health Promotion Hospital. Journal of The Royal Thai Army Nurses. 2018; 19 (Supplement), 193-202. (in Thai)

18. Poomsanguan K. Health and Health promotion: Nurse. Journal of The Royal Thai Army Nurses. 2014; 15(2), 10-14. (in Thai)

19. Srisawad K, Panyapinijnukul C, Ausdorndacha S. Nurse’s Role for Teenage Pregnancy. Journal of The Royal Thai Army Nurses. 2018; 19 (Supplement), 1-7. (in Thai)